Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model
Background: Pharmacokinetics of warfarin has not been described in our population. We derived the pharmacokinetic parameters from a validated pharmacokinetic-pharmacodynamic model. Methods: Patients receiving warfarin for at least 6 months were recruited and their demographic characteristics, prothr...
Saved in:
Main Authors: | Kannan Sridharan (Author), Rashed Al Banna (Author), Aysha Husain (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects
by: Isabelle Zenklusen, et al.
Published: (2024) -
A physiologically‐based pharmacokinetic/pharmacodynamic modeling approach for drug-drug‐gene interaction evaluation of S‐warfarin with fluconazole
by: Kuo Geng, et al.
Published: (2024) -
Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
by: Jung JA, et al.
Published: (2015) -
Influence of andrographolide on the pharmacokinetics of warfarin in rats
by: Xiaoli Zhang, et al.
Published: (2018) -
Critical pharmacokinetic and pharmacodynamic drug-herb interactions in rats between warfarin and pomegranate peel or guava leaves extracts
by: Maisa Alnaqeeb, et al.
Published: (2019)